AI-Fueled Generate Maps Out Path To Clinic Over Next 24 Months

The biotech company already has a candidate with a tough target in the clinic for COVID-19 and plans to have four to six candidates in the clinic over the next two years following a $273m series C round.

Generate Biomedicines announced a $273m series C funding round • Source: Shutterstock

More from AI

More from Digital Technologies